Comparative efficacy of VIP and analogs on activation and internalization of the recombinant VPAC2 receptor expressed in CHO cells

Using a monoclonal antibody interacting with the extracellular amino-terminus of the human VPAC2 receptor but that did not interfere with ligand binding, we measured by flow cytometry receptor internalization and trafficking induced by full agonists, partial agonists and an antagonist in Chinese ham...

Full description

Saved in:
Bibliographic Details
Published in:Peptides (New York, N.Y. : 1980) N.Y. : 1980), 2004-12, Vol.25 (12), p.2079-2086
Main Authors: LANGLET, Christelle, GASPARD, Nathalie, NACHTERGAEL, Ingrid, ROBBERECHT, Patrick, LANGER, Ingrid
Format: Article
Language:English
Subjects:
Adenylyl Cyclases - metabolism
Animals
Antibodies, Monoclonal
Biological and medical sciences
Cell receptors
Cell structures and functions
CHO Cells
Colforsin - pharmacology
Cricetinae
Enzyme Activation
Flow Cytometry
Fundamental and applied biological sciences. Psychology
Humans
Kinetics
Molecular and cellular biology
Neuropeptide receptors
Peptides, Cyclic - pharmacology
Phorbol Esters - pharmacology
Receptors, Vasoactive Intestinal Peptide - metabolism
Receptors, Vasoactive Intestinal Peptide, Type II
Recombinant Proteins - metabolism
Time Factors
Vasoactive Intestinal Peptide - agonists
Vasoactive Intestinal Peptide - pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Using a monoclonal antibody interacting with the extracellular amino-terminus of the human VPAC2 receptor but that did not interfere with ligand binding, we measured by flow cytometry receptor internalization and trafficking induced by full agonists, partial agonists and an antagonist in Chinese hamster ovary cells expressing the recombinant receptor. The agonists, but not the antagonist, induced a rapid, dose-dependent receptor internalization blocked by hypertonic sucrose that was more pronounced for the VIP analog N-hexanoyl-VIP (80%) than for VIP and Ro 25-1553 (50%) and the [A11]-VIP (20%). Re-expression of the receptors at the membrane was achieved within two hours after exposure to VIP and Ro 25-1553 was blocked by 25 microM monensin but not by 10 microg/ml cycloheximide. Re-expression was much slower after exposure to the acylated peptide and was blocked by preincubation with 25 microM monensin and 10 microg/ml cycloheximide.
ISSN:0196-9781
1873-5169
DOI:10.1016/j.peptides.2004.08.017